Protagonist Therapeutics, Inc Increase (Decrease) in Contract with Customer, Liability
Protagonist Therapeutics, Inc (PTGX) reported Increase (Decrease) in Contract with Customer, Liability of $109.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-05
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was $3.38M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$3.27M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$7.44M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$3.08M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for fiscal 2025 was -$21.02M, a 168.76% decline from fiscal 2024.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for fiscal 2024 was $30.57M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for fiscal 2022 was -$1.60M.
- Protagonist Therapeutics, Inc increase (decrease) in contract with customer, liability for fiscal 2021 was -$12.88M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 9 month as first filed | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $109.00K 10-Q · filed 2026-08-05 | -$7.33M derived: sum of 3 quarters · filed 2026-08-05 | -$10.40M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$3.27M 10-Q · filed 2026-05-05 | -$10.71M derived: sum of 2 quarters · filed 2026-05-05 | -$13.78M derived: sum of 3 quarters · filed 2026-05-05 | -$18.79M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$7.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$10.51M derived: sum of 2 quarters · filed 2026-02-25 | -$15.52M derived: sum of 3 quarters · filed 2026-08-05 | -$21.02M 10-K · filed 2026-02-25 | |
| 2025-09-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.08M derived: sum of 2 quarters · filed 2026-08-05 | -$13.58M 10-Q · filed 2025-11-06 | -$19.22M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$10.50M 10-Q · filed 2026-08-05 | -$16.14M derived: sum of 3 quarters · filed 2026-08-05 | -$20.82M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$5.50M 10-Q · filed 2026-05-05 | -$11.13M derived: sum of 2 quarters · filed 2026-05-05 | -$15.81M derived: sum of 3 quarters · filed 2026-05-05 | -$19.98M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | -$5.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$10.31M derived: sum of 2 quarters · filed 2026-02-25 | -$14.48M derived: sum of 3 quarters · filed 2026-02-25 | $30.57M 10-K · filed 2026-02-25 | |
| 2024-09-30 | -$4.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.84M derived: sum of 2 quarters · filed 2025-11-06 | $36.20M 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $40.88M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | $45.05M 10-Q · filed 2025-05-06 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | $0.00 derived: sum of 2 quarters · filed 2025-02-21 | -$768.00K derived: sum of 3 quarters · filed 2025-02-21 | -$1.60M 10-K · filed 2025-02-21 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$768.00K derived: sum of 2 quarters · filed 2023-11-02 | -$1.60M 10-Q · filed 2023-11-02 | -$2.24M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$1.60M 10-Q · filed 2023-08-03 | -$2.24M derived: sum of 3 quarters · filed 2024-02-27 | -$2.01M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | -$833.00K 10-Q · filed 2023-05-04 | -$1.47M derived: sum of 2 quarters · filed 2024-02-27 | -$1.24M derived: sum of 3 quarters · filed 2024-02-27 | -$5.00M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | -$640.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$408.00K derived: sum of 2 quarters · filed 2024-02-27 | -$4.17M derived: sum of 3 quarters · filed 2024-02-27 | -$12.88M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $232.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.53M derived: sum of 2 quarters · filed 2022-11-08 | -$12.24M 10-Q · filed 2022-11-08 | -$18.64M derived: sum of 4 quarters · filed 2023-03-15 | |
| 2021-06-30 | -$3.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$12.47M 10-Q · filed 2022-08-04 | -$18.87M derived: sum of 3 quarters · filed 2023-03-15 | -$32.00M derived: sum of 4 quarters · filed 2023-03-15 | |
| 2021-03-31 | -$8.71M 10-Q · filed 2022-05-05 | -$15.11M derived: sum of 2 quarters · filed 2023-03-15 | -$28.25M derived: sum of 3 quarters · filed 2023-03-15 | -$33.28M derived: sum of 4 quarters · filed 2023-03-15 | |
| 2020-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$19.54M derived: sum of 2 quarters · filed 2023-03-15 | -$24.57M derived: sum of 3 quarters · filed 2023-03-15 | -$27.05M 10-K · filed 2023-03-15 | |
| 2020-09-30 | -$13.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$18.17M derived: sum of 2 quarters · filed 2021-11-03 | -$20.65M 10-Q · filed 2021-11-03 | $14.06M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$7.52M 10-Q · filed 2021-08-04 | $27.20M derived: sum of 3 quarters · filed 2022-02-28 | -$7.55M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$2.48M 10-Q · filed 2021-05-04 | $32.23M derived: sum of 2 quarters · filed 2022-02-28 | -$2.52M derived: sum of 3 quarters · filed 2022-02-28 | $32.04M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $34.72M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$37.00K derived: sum of 2 quarters · filed 2022-02-28 | $34.53M derived: sum of 3 quarters · filed 2022-02-28 | $33.31M 10-K · filed 2022-02-28 | |
| 2019-09-30 | -$34.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$187.00K derived: sum of 2 quarters · filed 2020-11-04 | -$1.41M 10-Q · filed 2020-11-04 | $30.45M 10-Q · filed 2019-11-06 | -$1.16M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | $34.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $33.34M 10-Q · filed 2020-08-06 | $33.60M derived: sum of 3 quarters · filed 2021-03-10 | $28.36M derived: sum of 4 quarters · filed 2021-03-10 | |
| 2019-03-31 | -$1.22M 10-Q · filed 2020-05-07 | -$969.00K derived: sum of 2 quarters · filed 2021-03-10 | -$6.20M derived: sum of 3 quarters · filed 2021-03-10 | -$14.88M derived: sum of 4 quarters · filed 2021-03-10 | |
| 2018-12-31 | $253.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | -$4.98M derived: sum of 2 quarters · filed 2021-03-10 | -$13.66M derived: sum of 3 quarters · filed 2021-03-10 | -$23.53M 10-K · filed 2021-03-10 | |
| 2018-09-30 | -$5.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$13.91M derived: sum of 2 quarters · filed 2019-11-06 | -$23.78M 10-Q · filed 2019-11-06 | -$33.77M derived: sum of 4 quarters · filed 2020-03-10 | |
| 2018-06-30 | -$8.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$18.55M 10-Q · filed 2019-08-07 | -$28.54M derived: sum of 3 quarters · filed 2020-03-10 | ||
| 2018-03-31 | -$9.87M 10-Q · filed 2019-05-08 | -$19.86M derived: sum of 2 quarters · filed 2020-03-10 | |||
| 2017-12-31 | -$9.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $31.75M 10-K · filed 2020-03-10 | |||
| 2017-09-30 | $41.74M 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |